Polycystic Ovary Syndrome (PCOS) - References

References

Citations

1. Barbieri RL (2002). Polycystic ovary syndrome. In DC Dale, DD Federman, eds., Scientific American Medicine, section 16, chap. 5. New York: WebMD.

   Related Articles

   • Polycystic Ovary Syndrome (PCOS) - Cause
   • Spironolactone for polycystic ovary syndrome (PCOS)

   » More resources Articles

2. Speroff L, Fritz MA (2005). Recurrent early pregnancy loss. In Clinical Gynecologic Endocrinology and Infertility, 7th ed., pp. 1069–1101. Philadelphia: Lippincott Williams and Wilkins.

3. Ehrmann DA (2005). Polycystic ovary syndrome. New England Journal of Medicine, 352(12): 1223–1236.

4. Speroff L, Fritz MA (2005). Anovulation and the polycystic ovary. Clinical Gynecologic Endocrinology and Infertility, 7th ed., pp. 465–498. Lippincott Williams and Wilkins.

5. Hershlag A, Peterson CM (2002). Endocrine disorders. In JS Berek, ed., Novak's Gynecology, 13th ed., pp. 871–930. Philadelphia: Lippincott Williams and Wilkins.

6. Elsenbruch S, et al. (2003). Quality of life, psychological well-being, and sexual satisfaction in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 88(12): 5801–5807.

7. Hunter MH, Sterrett JJ (2000). Polycystic ovary syndrome: It's not just infertility. American Family Physician, 62(5): 1079–1088.

8. Lobo RA, Carmina E (2000). The importance of diagnosing the polycystic ovary syndrome. Annals of Internal Medicine, 132(12): 989–993.

9. American Association of Clinical Endocrinologists (2005). Position statement on metabolic and cardiovascular consequences of polycystic ovary syndrome. Endocrine Practice: 11(2): 126–134.

10. Haas DA, et al. (2003). Effects of metformin on body mass index, menstrual cyclicity, and ovulation induction in women with polycystic ovary syndrome. Fertility and Sterility, 79(3): 469–481.

11. American College of Obstetricians and Gynecologists (2002). Management of infertility caused by ovulatory dysfunction. ACOG Practice Bulletin No. 34. Obstetrics and Gynecology, 99(2): 347–358.

12. Hatcher RA, et al. (2004). Combined (estrogen and progestin) contraceptives. In A Pocket Guide to Managing Contraception, pp. 97–119. Tiger, GA: Bridging the Gap Foundation.

13. Stegmann BJ, et al. (2003). Characteristics predictive of response to ovarian diathermy in women with polycystic ovarian syndrome. American Journal of Obstetrics and Gynecology, 188(5): 1171–1173.

Other Works Consulted

• Al-Inany H (2006). Polycystic ovary syndrome, search date October 2005. Online version of BMJ Clinical Evidence. Available online: http://www.clinicalevidence.com.

• American College of Obstetricians and Gynecologists (2002, reaffirmed 2006). Polycystic ovary syndrome. ACOG Practice Bulletin No. 41. Obstetrics and Gynecology, 100(6): 1389–1402.

• Dronavalli S, Ehrmann DA (2007). Pharmacologic therapy of polycystic ovary syndrome. Clinical Obstetrics and Gynecology, 50(1): 244–254.

• Hall J (2007). Neuroendocrine changes with reproductive aging in women. Seminars in Reproductive Medicine, 25(5): 344–351.

• Hatcher RA, et al. (2005). Combined (estrogen and progestin) contraceptives. In A Pocket Guide to Managing Contraception. 2005–2007 ed., pp. 101–123. Tiger, GA: Bridging the Gap Foundation.

• Legro RS, et al. (2007). Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. New England Journal of Medicine, 356(6): 551–566.

• Norman RJ, et al. (2007). Polycystic ovary syndrome. Lancet, (370)9588: 685–697.

• Practice Committee of the American Society for Reproductive Medicine (2006). The evaluation and treatment of androgen excess. Fertility and Sterility, 86(4, Suppl): S241–S247.

• Setji T, Brown AJ (2007). Polycystic ovary syndrome: Diagnosis and treatment. American Journal of Medicine, 120: 128–132.

• Thatcher SS (2000). Polycystic Ovary Syndrome: The Hidden Epidemic. Indianapolis: Perspectives Press.